Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Revenue

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹4,430 Cr₹3,999 Cr₹2,707 Cr₹1,945 Cr₹2,052 Cr

What is the latest Revenue of NATCO PHARMA ?

The latest Revenue ratio of NATCO PHARMA is ₹4,430 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹4,430 Cr
Mar2024₹3,999 Cr
Mar2023₹2,707 Cr
Mar2022₹1,945 Cr
Mar2021₹2,052 Cr

How is Revenue of NATCO PHARMA Trending?

Years Revenue % Change
Mar2025 ₹4,430 Cr
10.77
Mar2024 ₹3,999 Cr
47.72
Mar2023 ₹2,707 Cr
39.20
Mar2022 ₹1,945 Cr
-5.23
Mar2021 ₹2,052 Cr -

Compare Revenue of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,313.1 Cr -7% -29.3% 0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,785.0 Cr 0.4% -4.6% 6.9% Stock Analytics
DIVIS LABORATORIES ₹176,242.0 Cr 0.7% -1.1% 2.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,058.0 Cr 2.9% -1.2% 42.7% Stock Analytics
CIPLA ₹111,180.0 Cr -1.5% 5.5% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹106,149.0 Cr 0.4% -0.6% 1.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-7%

-29.3%

0.8%

SENSEX

-0.5%

-4.3%

-8.4%


You may also like the below Video Courses